Edge Biotechnologies ApS

CVR 44985977 · Private limited company (ApS) · Active · Medium risk

Edge Biotechnologies ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK -54k and a net result of DKK -104k. CEO: Ole Hjorth Krarup, Nikolaos Chatzakis.

Bankruptcy risk for Edge Biotechnologies ApS

1.6%
probability of bankruptcy within 12 months
Medium risk

1.1 × the average (1.41%) · higher risk than 79% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Equity ratio-50%–0% · bankruptcy rate 14.8%1.7×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Website registeredYes · bankruptcy rate 12.0%1.4×

Reduces the risk

Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Number of CEOs2 · bankruptcy rate 5.7%0.65×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44985977
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
c/o Nicolaos Chatzakis, Spurvevej 10
2970 Hørsholm
Municipality
Hørsholm
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 50k
Auditor
ALBJERG, Statsautoriseret Revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityYes
Equity ratio-38.8%
Current ratio169%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address1
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK 11k
Net profitDKK -104k
EquityDKK -54k
Total assetsDKK 138k
CashDKK 138k
Short-term debtDKK 82k
Avg. employees2

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · ALBJERG, Statsautoriseret Revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
30 Jul 2024 – 31 Dec 2025176

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOOle Hjorth KrarupCurrent
CEONikolaos ChatzakisCurrent
Owner (33%)Edge BT Holding ApSCurrent
Owner (50%)Hatzakis Holding ApSCurrent
FounderEdge BT Holding ApSCurrent
FounderHatzakis Holding ApSCurrent

The CEOs' other companies

Ole Hjorth Krarup – 3 other companies

Nikolaos Chatzakis – 1 other companies

Address history (1 moves)

c/o Nicolaos Chatzakis, Spurvevej 10, 2970 Hørsholm
Spurvevej 10, 2970 Hørsholm

Other companies at the same address

Similar companies in Hørsholm

Questions and answers about Edge Biotechnologies ApS

Has Edge Biotechnologies ApS gone bankrupt?

No, Edge Biotechnologies ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Edge Biotechnologies ApS?

Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.

Who is the CEO of Edge Biotechnologies ApS?

Ole Hjorth Krarup, Nikolaos Chatzakis are the CEOs of Edge Biotechnologies ApS.

Who is the auditor of Edge Biotechnologies ApS?

Edge Biotechnologies ApS most recently used ALBJERG, Statsautoriseret Revisionsaktieselskab.

When was Edge Biotechnologies ApS founded?

Edge Biotechnologies ApS was founded on 30 July 2024.

What is the equity of Edge Biotechnologies ApS?

Equity was DKK -54k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.